Will a U.S. Listing Significantly Boost These 2 Marijuana Stocks?

Could Canopy Growth Corp. (TSX:WEED) and Aurora Cannabis Inc. (TSX:ACB) get a +36% boost from a U.S. listing?

| More on:

Listed Canadian marijuana producers are making frantic efforts to dual list their equity stock securities on leading U.S. exchanges, specifically, the NASDAQ stock market and the New York Stock Exchange, but could they enjoy the same success as Cronos Group Inc. (TSXV:CRON)(NASDAQ:CRON)?

The desire by the leading marijuana stocks to list south of the boarder has been recently sparked by the massive stock price gain achieved by the smaller but rapidly growing cannabis firm, when it announced it is getting listed on a major American stock exchange on February 26.

Cronos Group stock debuted trading on the NASDAQ Stock Exchange on February 27 to much market applause, as it was the first ever marijuana grower to ever list its shares on a major U.S. exchange. The stock rose nearly 36% from its February 26th closing price to peak at $13.39 per share on March 6.

The cannabis firm labelled the NASDAQ listing as a “major corporate milestone” and believes the move will “increase long-term shareholder value by improving awareness, liquidity, and appeal to institutional investors.”

Indeed, the market welcomed the move and rewarded the stock accordingly.

As if not to be left out, Canopy Growth Corp. (TSX:WEED) and Aurora Cannabis Inc. (TSX:ACB) made it into the headlines afterwards; Canopy revealed that it already had plans to list on the NASDAQ before, but had halted the move while going through negotiations and concluding a major deal with Constellation Brands, and Aurora’s CEO mentioned that he will look at the NASDAQ, the New York Stock Exchange, as well as AIM in the United Kingdom.

As it seems, Canopy may list earlier on the NASDAQ, as it looks to have worked on the plan for some time, but will these leading marijuana firms reap the same benefits and see their stock prices rise as much as Cronos Group’s +36%?

They probably won’t rise as much.

Aurora’s and Canopy’s shares will most likely gain in value upon debuting trading on American exchanges due to a number of factors, like more visibility among American investors, improved market depth, elevated price discovery, as well the all-important influx of large U.S institutional investors whose mandates may have limited them from trading in the shares while on the TSX, among other positive factors.

However, Canopy and Aurora have been enjoying most of the benefits associated with listing on a major world stock exchange by virtue of them trading on the main TSX already.

Cronos Group was only listed on a smaller and junior TSX Venture exchange, where there are a majority of smaller issuers, and therefore it had so much to benefit by being traded alongside world corporate giants — the likes of Apple Inc., Amazon.com and Microsoft Corp. — and the move has helped shrug off some stigma associated with pot stocks in the United States.

Furthermore, Cronos Group may not have been as popular as Canopy and Aurora are among world investors due to being smaller in size and trading on a smaller exchange, while Canopy has been included in the S&P/TSX Composite, which is replicated by several institutional money managers, who use it as a performance benchmark.

Canopy and Aurora already trade on the main Canadian exchange, which is very much accessible, even to U.S. institutional investors, unlike Cronos Group, which is listed on the TSXV, where some institutional investors may have had limited access to the stock due to internal or fund specific constraints.

Most noteworthy, Aurora has been topping the list on the most traded TSX stocks and trending stocks lists on numerous trading days since last year, so added exposure may not boost the stock as significantly as it did for Cronos Group.

Foolish bottom line

Canopy and Aurora may have already attracted a significant number of institutional and retail investors, so they may not benefit as much as Cronos Group from a NASDAQ listing. Making a speculative trade based on the listing of the two stocks on major U.S. exchanges is not a guaranteed profitable action.

That said, dual listing would deepen capital market exposure to the stocks, improve liquidity, and most likely support a higher bottom on the stocks, which is good for long-term investors in the three stocks discussed.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Teresa Kersten is an employee of LinkedIn and is a member of The Motley Fool’s board of directors. LinkedIn is owned by Microsoft. Fool contributor Brian Paradza has no position in any of the stocks mentioned. David Gardner owns shares of Amazon and Apple. The Motley Fool owns shares of Amazon and Apple and has the following options: long January 2020 $150 calls on Apple and short January 2020 $155 calls on Apple.

More on Investing

Tractor spraying a field of wheat
Investing

Is Nutrien Stock a Buy for its 4.7% Dividend Yield?

Nutrien (TSX:NTR) is a well-known defensive commodities play. But is this stock worth buying for its dividend yield alone?

Read more »

Happy shoppers look at a cellphone.
Tech Stocks

So You Own Shopify Stock: Is it Still a Good Investment?

Shopify (TSX:SHOP) stock has had a run, but there's still room to the upside.

Read more »

Paper Canadian currency of various denominations
Investing

The Best Stocks to Invest $2,000 in Right Now

Do you have some extra cash to spare? Here are three Canadian stocks to add to your watch list today.

Read more »

tsx today
Stock Market

TSX Today: What to Watch for in Stocks on Friday, November 22

Continued gains in gold, oil, and natural gas prices could give the commodity-focused TSX benchmark a boost at the opening…

Read more »

Train cars pass over trestle bridge in the mountains
Dividend Stocks

Is CNR Stock a Buy, Sell, or Hold for 2025?

Can CNR stock continue its long-term outperformance into 2025 and beyond? Let's explore whether now is a good time to…

Read more »

engineer at wind farm
Energy Stocks

Invest $20,000 in This Dividend Stock for $100 in Monthly Passive Income

This dividend stock has it all – a strong outlook, monthly income, and even more to consider buying today.

Read more »

Hourglass and stock price chart
Stock Market

It’s Not Too Late: Invest in These TSX Growth Stocks Now

Solid fundamentals of these top TSX growth stocks could help them maintain strong upward momentum in the years to come.

Read more »

coins jump into piggy bank
Dividend Stocks

The Smartest Dividend Stocks to Buy With $500 Right Now

These top dividend stocks both offer attractive yields and trade off their highs, making them two of the best to…

Read more »